Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãåíåòèêà

 
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 06.06.2012, 11:16
irinka1385 irinka1385 âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 01.06.2012
Ãîðîä: ×åëÿáèíñê
Ñîîáùåíèé: 3
Ñêàçàë(à) ñïàñèáî: 1
irinka1385 *
â ãåíîòèïå æåíû îáíàðóæåí HLA B27:xx, ïðåäïîëàãàþùèé ê ðàçâèòèþ áîëåçíè Áåõòåðåâà

Çäðàâñòâóéòå. Ïîìîãèòå, ïîæàëóéñòà! Ìíå 27 ëåò. ÈÌÒ 33,5.  àíàìíåçå 3 áåðåìåííîñòè: 2 ðåãðåññèðóþùèå íà ìàëûõ ñðîêàõ (6-7 íåäåëü). è 1-ïðåðûâàíèå ïî-ìåä. ïîêàçàíèÿì íà ñðîêå 27-28 íåäåëü( ìàëîå êåñàðåâî ñå÷åíèå)- ÂÏÑ ïëîäà, ÄÌÆÏ, äâîéíîé âûõîä ñïðàâà ãëàâíûõ àðòåðèé ñ òðàíïîçèöèåé ñîñóäîâ, ñòåíîç ëåãî÷íîãî ñòâîëà, ãèïåðòðîôèÿ ïðàâîãî æåëóäî÷êà.
Ñäàííûå àíàëèçû:
Öèòîìåãàëîâèðóñ IgG 467,4 åä/ìë; IgM- íå îáíàðóæåí

Ïðîëàêòèí 695 ìÅä/ë (ïîñòàâèëè ôóíêöèîíàëüíóþ ãèïåðïðîëàêòèìèþ; ôèáðîçíî-êèñòîçíóþ ìàñòîïàòèþ) Íàçíà÷åíî ëå÷åíèå: äîñòèíåêñ, öèêëîäèíîí, ïðîæåñòîæåëü.

Âîë÷àíî÷íûé àíòèêîàãóëÿíò îáíàðóæåí (ýôôåêò ñëàáî âûðàæåí)

Ãîìîöèñòåèí 9,67 (óìåíÿ) 7,09 (ó ìóæà)

Ïîëèìîðôèçìû ãåíîâ:
F5 Arg 506 Gln- ìóòàöèÿ íå îáíàðóæåíà
F2 20210 G A - ìóòàöèÿ íå îáíàðóæåíà
MTHFR +/MTHFR Ala222Val- ãåòåðîçèãîòà
FGB+/FGB 455 G/A - ãåòåðîçèãîòà
PAI-1+/PAI-1(675 4G/5G) - ãåòåðîçèãîòà
GP IIIA+/GP IIIA Leu 33Pro - ãåòåðîçèãîòà
MTRR Ile22Met/ MTRR Ile22Met - ìóòàíòíàÿ ãîìîçèãîòà

Êàðèîòèïèðîâàíèå:
Ó ìåíÿ:
HLA-A 01:xx 24:xx
HLA-B 27:xx 35:xx
HLA-DRB1 07:xx 11:xx
HLA-DQA1 02:01 05:01
HLA-DQB1 02:01 03:01

Ó ìóæà:
HLA-A 01:xx 33:xx
HLA-B 13:xx 14:xx
HLA-DRB1 01:xx 07:xx
HLA-DQA1 01:01 02:01
HLA-DQB1 05:01 02:01
Çàêëþ÷åíèå: Ìóæ è æåíà ñîâïàäàþò ïî 4 ãåíàì HLA: A01:xx, DRB1*07:xx, DQA1*02:01, DQB1*02:01  ãåíîòèïå æåíû îáíàðóæåí HLA B27:xx, ïðåäïîëàãàþùèé ê ðàçâèòèþ áîëåçíè Áåõòåðåâà, ðåàêòèâíûì àðòðèòàì, ñèíäðîìó Ðåéòåðà.  ñûâîðîòêå æåíû àíòè HLA àíòèòåë íå îáíàðóæåíî. Âîçìîæíà èììóíèçàöèÿ æåíû ïî 6 ãåíàì: HLA: A33:xx, B13:xx, B14:xx, DQB1*01:xx, DQA1*01:01, DQB1*05:01.

Ãåìîñòàçèîãðàììà: ëåãêàÿ ãèïåðôèáðèíîãåíåìèÿ, ñëåãêà ïîâûøåí óðîâåíü ÐÔÌÊ, çàìåäëåí ýóãëîáóë.ëèçèñ

Ïîäñêàæèòå, ïîæàëóéñòà, ðàñøèôðîâàòü ìîè ïîêàçàòåëè. Íàñêîëüêî ýòî ñåðüåçíî? Ñìîæåì ëè ìû ðîäèòü çäîðîâîãî ðåáåíêà? ×òî äåëàòü äàëüøå?
Îòâåòèòü ñ öèòèðîâàíèåì
 



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 13:52.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.